Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties. (Q40117639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579831%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579831%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579831%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Merlin Thomas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579831%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Josephine M. Forbes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579831%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Richard O'Brien

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579831%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

A Hoang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579831%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

M T Coughlan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579831%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

M E Cooper

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579831%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

J P F Chin-Dusting

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579831%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

D Sviridov

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579831%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

20 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579831%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579831%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579831%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579831%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1770-1779

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579831%20AND%20SRC:MED&resulttype=core&format=json

High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study

1 January 2020

cites work

1 reference

12 December 2020

Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol

1 reference

12 December 2020

Leukocyte ABCA1 gene expression is associated with fasting glucose concentration in normoglycemic men.

1 reference

12 December 2020

Apolipoprotein specificity for lipid efflux by the human ABCAI transporter

1 reference

12 December 2020

ABCA1. The gatekeeper for eliminating excess tissue cholesterol.

1 reference

12 December 2020

Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.

1 reference

12 December 2020

The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.

1 reference

12 December 2020

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

12 December 2020

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

12 December 2020

Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products

1 reference

12 December 2020

Apolipoprotein A-I lysine modification: effects on helical content, lipid binding and cholesterol acceptor activity

1 reference

12 December 2020

Biochemistry and molecular cell biology of diabetic complications

1 reference

12 December 2020

Advanced glycation end products potentiate the stimulatory effect of glucose on macrophage lipoprotein lipase expression

1 reference

12 December 2020

Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport.

1 reference

12 December 2020

Circulating levels of nitrated apolipoprotein A-I are increased in type 2 diabetic patients

1 reference

12 December 2020

Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation

1 reference

12 December 2020

Antiinflammatory properties of HDL.

1 reference

12 December 2020

Differential regulation of apolipoprotein A-I/ATP binding cassette transporter A1-mediated cholesterol and phospholipid release

1 reference

12 December 2020

Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease

1 reference

12 December 2020

Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes

1 reference

12 December 2020

Nonenzymatic Glycosylation of HDL and Impaired HDL-Receptor–Mediated Cholesterol Efflux

1 reference

12 December 2020

HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphate

1 reference

12 December 2020

Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure

1 reference

12 December 2020

Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions

1 reference

12 December 2020

A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I.

1 reference

12 December 2020

Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1.

1 reference

12 December 2020

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

1 reference

12 December 2020

Glyoxalase System in Clinical Diabetes Mellitus and Correlation with Diabetic Complications

1 reference

12 December 2020

Why does diabetes increase atherosclerosis? I don't know!

1 reference

12 December 2020

Ability of serum to decrease cellular acylCoA:cholesterol acyl transferase activity predicts cardiovascular outcomes

1 reference

12 December 2020

Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells

1 reference

12 December 2020

High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients

1 reference

12 December 2020

Direct modulatory effect of C-reactive protein on primary human monocyte adhesion to human endothelial cells

1 reference

12 December 2020

Efflux of cellular cholesterol and phospholipid to apolipoprotein A-I mutants

1 reference

12 December 2020

Demethylation using the epigenetic modifier, 5-azacytidine, increases the efficiency of transient transfection of macrophages

1 reference

12 December 2020

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

1 reference

12 December 2020

Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I

1 reference

12 December 2020

Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.

1 reference

12 December 2020

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

1 reference

12 December 2020

Glycation of high-density lipoprotein does not increase its susceptibility to oxidation or diminish its cholesterol efflux capacity

1 reference

12 December 2020

Studies on the formation, separation, and characterization of cyanogen bromide fragments of human AI apolipoprotein

1 reference

12 December 2020

Structure-function studies of apoA-I variants: site-directed mutagenesis and natural mutations.

1 reference

12 December 2020

Efflux of intracellular versus plasma membrane cholesterol in HepG2 cells: different availability and regulation by apolipoprotein A-I

1 reference

12 December 2020

Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques?

1 reference

12 December 2020

Non-insulin dependent diabetes and reverse cholesterol transport

1 reference

12 December 2020

Advanced glycation: how are we progressing to combat this web of sugar anomalies in diabetic nephropathy

1 reference

12 December 2020

Nonenzymatic glycosylation of HDL resulting in inhibition of high-affinity binding to cultured human fibroblasts

1 reference

12 December 2020